Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Next Previous
Trial Profile

Phase III Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 11 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ibuprofen+sodium cromoglicate (Primary) ; Ibuprofen; Sodium cromoglicate
  • Indications Alzheimer's disease
  • Focus Registrational; Therapeutic Use
  • Acronyms COGNITE
  • Sponsors AZTherapies

    • Most Recent Events

    • 20 Nov 2020 Status changed from active, no longer recruiting to completed.
    • 18 Nov 2020 According to an AZTherapies media release, the company has completed the last patient/last visit in this study. Top-line data from this study is expected in the first quarter of 2021.
    • 22 Jul 2020 According to an AZTherapies media release, the company expects to complete this study in late 2020 and data unblinding in the first quarter of 2021.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top